摘要 |
<p>Treatment of schizophrenia or humans suffering from conditions associated with high dopamine levels in ventral striatum or caudate nucleus administers the compound (2S)-2-{3-[3-({[(2R,4R)-4-tert-Butoxycarbonyl-2-(2-fluorophenyl)]-3-thiazolidinyl} carbonylmethyl) ureido]phenyl} propionic acid and its physiological acceptable salts.</p> |